STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
33 hedge funds and large institutions have $17.6M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
88% less capital invested
Capital invested by funds: $147M → $17.6M (-$129M)
Holders
33
Holding in Top 10
1
Calls
$262K
Puts
$2K
Top Buyers
| 1 | +$253K | |
| 2 | +$246K | |
| 3 | +$220K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$196K |
| 5 |
Two Sigma Advisers
New York
|
+$106K |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$17.6M | |
| 3 | -$11.3M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$7.39M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.78M |